Diabetes Alert Day recognizes diabetes and its complications. One condition, known as diabetic peripheral neuropathy, affects ...

This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with ...

Chronic inflammatory demyelinating polyneuropathy (CIPD) can have a substantial impact on patients everyday life and, ...

Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...

Okanagan Clinical Trials is looking for individuals aged between 19 and 80, who are currently experiencing chronic nerve pain ...

Neuropathy affects millions of people worldwide, causing chronic pain, numbness, weakness, and loss of function in the ...

Pivotal study in MG met primary endpoint of change from baseline in MG-ADL in AChR+ population at 12 weeks, with a 5.6 point improvement in the ...

Alnylam Pharmaceuticals gains FDA approval for Amvuttra in ATTR-CM, boosting revenue prospects. Click here to read an ...

Hand cooling and compression are highly effective in preventing chemotherapy-induced peripheral neuropathy, according to a ...

Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM) field, Alnylam is hoping its RNA ...

Along with tafamidis and acoramidis, the drug is now the third for ATTR-CM, but it comes with a whopping price tag of ...